Guideline for Isolation Precautions: Preventing ...
Accessable version:
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings
Last update: July 2019 Jane D. Siegel, MD; Emily Rhinehart, RN MPH CIC; Marguerite Jackson, PhD; Linda Chiarello, RN MS; the Healthcare Infection Control Practices Advisory Committee Acknowledgement: The authors and HICPAC gratefully acknowledge Dr. Larry Strausbaugh for his many contributions and valued guidance in the preparation of this guideline. Suggested citation: Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings
Page 1 of 206
Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007)
Healthcare Infection Control Practices Advisory Committee (HICPAC):
Chair Patrick J. Brennan, MD Professor of Medicine Division of Infectious Diseases University of Pennsylvania Medical School
Executive Secretary Michael Bell, MD Division of Healthcare Quality Promotion National Center for Infectious Diseases Centers for Disease Control and Prevention
Members BRINSKO, Vicki L., RN, BA Infection Control Coordinator Vanderbilt University Medical Center
DELLINGER, E. Patchen., MD Professor of Surgery University of Washington School of Medicine
ENGEL, Jeffrey, MD Head General Communicable Disease Control Branch North Carolina State Epidemiologist
GORDON, Steven M., MD Chairman, Department of Infections Diseases Hospital Epidemiologist Cleveland Clinic Foundation Department of Infectious Disease
HARRELL, Lizzie J., PhD, D(ABMM) Research Professor of Molecular Genetics, Microbiology and Pathology Associate Director, Clinical Microbiology Duke University Medical Center
O'BOYLE, Carol, PhD, RN Assistant Professor, School of Nursing University of Minnesota
PEGUES, David Alexander, MD Division of Infectious Diseases David Geffen School of Medicine at UCLA
PERROTTA, Dennis M. PhD., CIC Adjunct Associate Professor of Epidemiology University of Texas School of Public Health Texas A&M University School of Rural Public Health
PITT, Harriett M., MS, CIC, RN Director, Epidemiology Long Beach Memorial Medical Center
RAMSEY, Keith M., MD Professor of Medicine Medical Director of Infection Control The Brody School of Medicine at East Carolina University
SINGH, Nalini, MD, MPH Professor of Pediatrics Epidemiology and International Health The George Washington University Children's National Medical Center
STEVENSON, Kurt Brown, MD, MPH Division of Infectious Diseases Department of Internal Medicine The Ohio State University Medical Center
SMITH, Philip W., MD Chief, Section of Infectious Diseases Department of Internal Medicine University of Nebraska Medical Center
HICPAC membership (past)
Robert A. Weinstein, MD (Chair) Cook County Hospital Chicago, IL
Jane D. Siegel, MD (Co-Chair) University of Texas Southwestern Medical Center Dallas, TX
Michele L. Pearson, MD (Executive Secretary) Centers for Disease Control and Prevention Atlanta, GA
Last update: July 2019
Page 2 of 206
Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007)
Raymond Y.W. Chinn, MD Sharp Memorial Hospital San Diego, CA
Lorine J. Jay MPH, RN, CPHQ Liaison to Healthcare Resources Services Administration
Alfred DeMaria, Jr, MD Massachusetts Department of Public Health Jamaica Plain, MA
Stephen F. Jencks, MD, MPH Liaison to Center for Medicare and Medicaid Services
James T. Lee, MD, PhD University of Minnesota Minneapolis, MN
William A. Rutala, PhD, MPH University of North Carolina Health Care System Chapel Hill, NC
William E. Scheckler, MD University of Wisconsin Madison, WI
Beth H. Stover, RN Kosair Children's Hospital Louisville, KY
Marjorie A. Underwood, RN, BSN CIC Mt. Diablo Medical Center Concord, CA
HICPAC Liaisons William B. Baine, MD Liaison to Agency for Healthcare Quality Research
Joan Blanchard, RN, MSN, CNOR Liaison to Association of periOperative Registered Nurses
Patrick J. Brennan, MD Liaison to Board of Scientific Counselors
Nancy Bjerke, RN, MPH, CIC Liaison to Association of Professionals in Infection Prevention and Control
Jeffrey P. Engel, MD Liaison to Advisory Committee on Elimination of Tuberculosis
David Henderson, MD Liaison to National Institutes of Health
Sheila A. Murphey, MD Liaison to Food and Drug Administration
Mark Russi, MD, MPH Liaison to American College of Occupational and Environmental Medicine
Rachel L. Stricof, MPH Liaison to Advisory Committee on Elimination of Tuberculosis
Michael L. Tapper, MD Liaison to Society for Healthcare Epidemiology of America
Robert A. Wise, MD Liaison to Joint Commission on the Accreditation of Healthcare Organizations
Authors' Associations Jane D. Siegel, MD Professor of Pediatrics Department of Pediatrics University of Texas Southwestern Medical Center
Emily Rhinehart RN MPH CIC CPHQ Vice President AIG Consultants, Inc.
Marguerite Jackson, RN PhD CIC Director, Administrative Unit, National Tuberculosis Curriculum Consortium, Department of Medicine University of California San Diego
Linda Chiarello, RN MS Division of Healthcare Quality Promotion National Center for Infectious Diseases, CDC
Last update: July 2019
Page 3 of 206
Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007)
TABLE OF CONTENTS
Updates ................................................................................................................................................................ 7
Executive Summary.............................................................................................................................................. 8
Parts I - III: Review of the Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings .......................................................................................................................................... 9
Tables, Appendices, and Other Information................................................................................................... 10 Appendix A: Type and Duration of Precautions Recommended for Selected Infections and Conditions . 10
Pre- Publication of the Guideline on Preventing Transmission of MDROs ..................................................... 11
Summary ........................................................................................................................................................ 11
Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings.......... 13
I.A. Evolution of the 2007 Document.............................................................................................................. 13 Changes or clarifications in terminology. .................................................................................................. 14 Scope. ........................................................................................................................................................ 14
I.B. Rationale for Standard and Transmission-Based Precautions in healthcare settings.............................. 15 I.B.1. Sources of infectious agents. ............................................................................................................ 15 I.B.2. Susceptible hosts. ............................................................................................................................. 15 I.B.3. Modes of transmission. .................................................................................................................... 16 I.B.3.a. Contact transmission.................................................................................................................16 I.B.3.a.i. Direct contact transmission. ............................................................................................... 16 I.B.3.a.ii. Indirect contact transmission. ........................................................................................... 17 I.B.3.b. Droplet transmission.................................................................................................................18 I.B.3.c. Airborne transmission. .............................................................................................................. 19 I.B.3.d. Emerging issues concerning airborne transmission of infectious agents. ................................ 20 I.B.3.d.i. Transmission from patients. ............................................................................................... 20 I.B.3.d.ii. Transmission from the environment. ................................................................................ 21 I.B.3.e. Other sources of infection. ....................................................................................................... 21
I.C. Infectious Agents of Special Infection Control Interest for Healthcare Settings....................................... 21 I.C.1. Epidemiologically important organisms. .......................................................................................... 22 I.C.1.a. C. difficile...................................................................................................................................22 I.C.1. b. Multidrug-resistant organisms (MDROs). ................................................................................ 23 I.C.2. Agents of bioterrorism......................................................................................................................24 I.C.2.a. Pre-event administration of smallpox (vaccinia) vaccine to healthcare personnel.......................25 I.C.3. Prions. ............................................................................................................................................... 25 I.C.4. Severe Acute Respiratory Syndrome (SARS).....................................................................................27 I.C.5. Monkeypox. ...................................................................................................................................... 29 I.C.6. Noroviruses.......................................................................................................................................30 I.C.7. Hemorrhagic fever viruses (HFV)......................................................................................................31
I.D. Transmission Risks Associated with Specific Types of Healthcare Settings ............................................. 32 I.D.1. Hospitals. .......................................................................................................................................... 33 I.D.1.a. Intensive care units. .................................................................................................................. 33 I.D.1.b. Burn units.................................................................................................................................. 33 I.D.1.c. Pediatrics...................................................................................................................................34 I.D.2. Non-acute healthcare settings. ........................................................................................................ 35 I.D.2.a. Long-term care..........................................................................................................................35 I.D.2.b. Ambulatory care. ...................................................................................................................... 37
Last update: July 2019
Page 4 of 206
Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007)
I.D.2.c. Home care. ................................................................................................................................ 38 I.D.2.d. Other sites of healthcare delivery. ........................................................................................... 39
I.E. Transmission Risks Associated with Special Patient Populations ............................................................. 39 I.E.1. Immunocompromised patients. ....................................................................................................... 40 I.E.2. Cystic fibrosis patients. ..................................................................................................................... 40
I.F. New Therapies Associated with Potentially Transmissible Infectious Agents .......................................... 41 I.F.1. Gene therapy. ................................................................................................................................... 41 I.F.2. Infections transmitted through blood, organs and other tissues. .................................................... 41 I.F.3. Xenotransplantation. ........................................................................................................................ 41
Part II: Fundamental Elements Needed to Prevent Transmission of Infectious Agents in Healthcare Settings ............................................................................................................................................ 43
II.A. Healthcare System Components that Influence the Effectiveness of Precautions to Prevent Transmission................................................................................................................................................... 43
II.A.1. Administrative measures.................................................................................................................43 II.A.1.a.Scope of work and staffing needs for infection control professionals. .................................... 43 II.A.1.a.i. Infection control nurse liaison...........................................................................................45 II.A.1.b. Bedside nurse staffing.............................................................................................................. 45 II.A.1.c. Clinical microbiology laboratory support. ................................................................................ 45
II.A.2. Institutional safety culture and organizational characteristics. ...................................................... 46 II.A.3. Adherence of healthcare personnel to recommended guidelines..................................................47
II.B. Surveillance for Healthcare-Associated Infections (HAIs) ....................................................................... 48
II.C. Education of HCWs, Patients, and Families............................................................................................. 49
II.D. Hand Hygiene.......................................................................................................................................... 50
II.E. Personal Protective Equipment (PPE) for Healthcare Personnel ............................................................. 51 II.E.1. Gloves. ............................................................................................................................................. 51 II.E.2. Isolation gowns. ............................................................................................................................... 52 II.E.3. Face protection: masks, goggles, face shields. ................................................................................ 53 II.E.3.a. Masks........................................................................................................................................53 II.E.3.b. Goggles, face shields. ............................................................................................................... 54 II.E.4. Respiratory protection.....................................................................................................................55
II.F. Safe Work Practices to Prevent HCW Exposure to Bloodborne Pathogens ............................................. 57 II.F.1. Prevention of needlesticks and other sharps-related injuries. ........................................................ 57 II.F.2. Prevention of mucous membrane contact. ..................................................................................... 57 II.F.2.a. Precautions during aerosol-generating procedures.................................................................57
II.G. Patient Placement................................................................................................................................... 58 II.G.1. Hospitals and long-term care settings.............................................................................................58 II.G.2. Ambulatory settings. ....................................................................................................................... 60 II.G.3. Home care. ...................................................................................................................................... 61
II.H. Transport of Patients .............................................................................................................................. 61
II.I. Environmental Measures.......................................................................................................................... 61
II.J. Patient Care Equipment and Instruments/Devices .................................................................................. 62
II.K. Textiles and Laundry................................................................................................................................ 63
II.L. Solid Waste .............................................................................................................................................. 64
II.M. Dishware and Eating Utensils ................................................................................................................ 64
Last update: July 2019
Page 5 of 206
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- transmission based precautions
- implementation of personal protective equipment in nursing
- evidence based best practices infection control and
- isolation policy transmission based precautions
- the end of the attendees will be able transmission‐based
- cms rule toolkit for long term care facilities
- transmission ased precautions laramie wyoming
- guideline for isolation precautions preventing
- infection prevention standard and transmission based
- standardization of isolation precaution signage in washington
Related searches
- isolation precautions for pink eye
- guideline for isolation precautions cdc 2019
- cdc guidelines for isolation precautions 2
- isolation precautions for latent tb
- cdc guidelines for isolation precautions 2019
- isolation precautions for tb
- guidelines for isolation precautions in hospitals
- isolation precautions for influenza a
- cdc guideline for isolation precautions
- isolation precautions for influenza
- isolation precautions for conjunctivitis
- isolation precautions for flu patients